Skip to main content
Institute for Global Health & Infectious Diseases

2012

 

  1. Samuel JC, Sankhulani E, Qureshi JS, et al. Under-reporting of road traffic mortality in developing countries: application of a capture-recapture statistical model to refine mortality estimates. PLoS One 2012;7:e31091.
  2. Samuel JC, Msiska N, Muyco AP, Cairns BA, Charles AG. An observational study addressing the anatomic basis of mesosigmoidopexy as a rational treatment of non-gangrenous sigmoid volvulus. Trop Doct 2012;42:44-5.
  3. Bartlett JA, Ribaudo HJ, Wallis CL, et al. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS 2012;26:1345-54.
  4. Johnson DC, Chasela C, Maliwichi M, et al. Tenofovir Use and Renal Insufficiency among Pregnant and General Adult Population of HIV-infected, ART-Naive Individuals in Lilongwe, Malawi. PLoS ONE 2012;7:e41011.
  5. Kim MH, Ahmed S, Buck WC, et al. The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi. J Int AIDS Soc 2012;15:1-11.
  6. Lockman S, Hughes M, Sawe F, et al. Nevirapine- Versus Lopinavir/Ritonavir-Based Initial Therapy for HIV-1 Infection among Women in Africa: A Randomized Trial. PLoS Med 2012;9:e1001236.
  7. McCollum ED, Johnson DC, Chasela CS, et al. Superior Uptake and Outcomes of Early Infant Diagnosis of HIV Services at an Immunization Clinic Versus an “Under-Five” General Pediatric Clinic in Malawi. J Acquir Immune Defic Syndr 2012;60:e107-10.
  8. Luebbert J, Tweya H, Phiri S, et al. Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in lilongwe, Malawi. Clin Infect Dis 2012;55:441-8.
  9. Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, et al. Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program. Clin Infect Dis 2012;54 Suppl 4:S362-8.
  10. Wadonda-Kabondo N, Hedt BL, van Oosterhout JJ, et al. A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi. Clin Infect Dis 2012;54 Suppl 4:S355-61.
  11. Jamieson DJ, Chasela CS, Hudgens MG, et al. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet 2012;379:2449-58.
  12. Jackson AT, Nussbaum JC, Phulusa J, et al. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis. AIDS 2012;26:1363-70.
  13. Skinner-Adams TS, Butterworth AS, Porter KA, et al. The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS ONE 2012;7:e34399.
  14. Weigel R, Hosseinipour MC, Feldacker C, et al. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi. Trop Med Int Health 2012.
  15. Makoka MH, Miller WC, Hoffman IF, et al. Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance. BMC Infect Dis 2012;12:67.
  16. Wolf LL, Ibrahim R, Miao C, Muyco A, Hosseinipour MC, Shores C. Esophagogastroduodenoscopy in a public referral hospital in Lilongwe, Malawi: spectrum of disease and associated risk factors. World J Surg 2012;36:1074-82.
  17. Kayira D, Bentley ME, Wiener J, et al. A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr 2012;95:759-65.
  18. Porter KA, Cole SR, Eron JJ, Jr., et al. HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother 2012;56:995-1000.
  19. Brown KC, Hosseinipour MC, Hoskins JM, et al. Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians. Pharmacogenomics 2012;13:113-21.
  20. Chavula C, Long D, Mzembe E, et al. Stopping the control arm in response to the DSMB: mother’s choice of HIV prophylaxis during breastfeeding in the BAN Study. Contemp Clin Trials 2012;33:55-9.
  21. Safren SA, Hendriksen ES, Smeaton L, et al. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS Behav 2012;16:266-77.
  22. Campbell TB, Smeaton LM, Kumarasamy N, et al. Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings. PLoS Med 2012;9:e1001290.
  23. Vorkas CK, Tweya H, Mzinganjira D, et al. Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, Malawi. Trop Med Int Health 2012;17:169-76.
  24. Keating MA, Hamela G, Miller WC, Moses A, Hoffman IF, Hosseinipour MC. High HIV Incidence and Sexual Behavior Change among Pregnant Women in Lilongwe, Malawi: Implications for the Risk of HIV Acquisition. PLoS ONE 2012;7:e39109.
  25. Chasela CS, Wall P, Drobeniuc J, et al. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol 2012;54:318-20.
  26. Rosenberg NE, Kamanga G, Phiri S, et al. Point-of-Care Diagnostics for Acute HIV Infection: An Important Public Health Priority. J Infect Dis 2012;206:1949-50.
  27. Bailey JA, Mvalo T, Aragam N, et al. Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi. J Infect Dis 2012;206:580-7.
  28. Brown LB, Miller WC, Kamanga G, et al. Predicting partner HIV testing and counseling following a partner notification intervention. AIDS Behav 2012;16:1148-55.
  29. Woodsong C, Alleman P, Musara P, et al. Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS Behav 2012;16:785-90.
  30. Violari A, Lindsey JC, Hughes MD, et al. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. N Engl J Med 2012;366:2380-9.
  31. Feldacker C, Johnson D, Hosseinipour M, Phiri S, Tweya H. Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi. PLoS One 2012;7:e50871.
  32. Kiser MM, Samuel JC, McLean SE, Muyco AP, Cairns BA, Charles AG. Epidemiology of pediatric injury in Malawi: Burden of disease and implications for prevention. Int J Surg 2012;10:611-7.
  33. Robertson K, Jiang H, Kumwenda J, et al. Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study. Clin Infect Dis 2012.
  34. Olson D, Gulley ML, Tang W, et al. Phase I Clinical Trial of Valacyclovir and Standard of Care Cyclophosphamide in Children With Endemic Burkitt Lymphoma in Malawi. Clinical lymphoma, myeloma & leukemia 2012.
  35. Gorbach PM, Mensch BS, Husnik M, et al. Effect of Computer-Assisted Interviewing on Self-Reported Sexual Behavior Data in a Microbicide Clinical Trial. AIDS Behav 2012.
  36. Chirenje ZM, Masse BR, Maslankowski LA, et al. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. J Int AIDS Soc 2012;15:17376.
  37. Vorkas C, Kayira D, van der Horst C, et al. Tuberculosis Drug Resistance and Outcomes among Tuberculosis Inpatients in Lilongwe, Malawi. Malawi Med J 2012;24:21-4.
  38. Lippmann QK, Mofolo I, Bobrow E, et al. Exploring the feasibility of engaging Traditional Birth Attendants in a prevention of Mother to Child HIV Transmission program in Lilongwe, Malawi. Malawi Med J 2012;24:79-80.
  39. Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J Infect Dis 2012;205:528-34.
  40. Ramlal RT, Tembo M, Soko A, et al. Patterns of Body Composition Among HIV-Infected, Pregnant Malawians and the Effects of Famine Season. Matern Child Health J 2012.
  41. Flax VL, Bentley ME, Chasela CS, et al. Use of Lipid-Based Nutrient Supplements by HIV-Infected Malawian Women during Lactation Has No Effect on Infant Growth from 0 to 24 Weeks. J Nutr 2012.
  42. Dow A, Kayira D, Hudgens M, et al. The Effects of Cotrimoxazole Prophylactic Treatment on Adverse Health Outcomes among Human Immunodeficiency Virus-Exposed, Uninfected Infants. Pediatr Infect Dis J 2012.
  43. Ramlal RT, Tembo M, Soko A, et al. Maternal Mid-Upper Arm Circumference Is Associated With Birth Weight Among HIV-Infected Malawians. Nutr Clin Pract 2012;27:416-21.